InMed Pharmaceuticals Inc. (INM)
NASDAQ: INM · Real-Time Price · USD
3.360
+0.740 (28.24%)
At close: May 14, 2025, 4:00 PM
3.289
-0.071 (-2.11%)
After-hours: May 14, 2025, 7:59 PM EDT
InMed Pharmaceuticals Employees
InMed Pharmaceuticals had 13 employees as of June 30, 2024. The number of employees did not change compared to the previous year.
Employees
13
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$378,538
Profits / Employee
-$639,346
Market Cap
4.06M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
INM News
- 2 days ago - InMed Reports Third Quarter Fiscal 2025 Financial Results and Provides Business Update - Newsfile Corp
- 3 months ago - InMed Reports Second Quarter Fiscal 2025 Financial Results and Provides Business Update - Newsfile Corp
- 3 months ago - InMed Announces INM-089 Intravitreal Formulation in the Treatment of Dry Age-Related Macular Degeneration - Newsfile Corp
- 4 months ago - InMed Pharmaceuticals Announces Granting of Patent for Novel Compounds - Newsfile Corp
- 4 months ago - InMed's INM-901 Demonstrates Statistically Significant Reduction in Neuroinflammation in a Long-Term Preclinical Alzheimer's Disease Study - Newsfile Corp
- 5 months ago - InMed Announces Results of 2024 Annual General Meeting - Newsfile Corp
- 5 months ago - InMed Enters Into Standby Equity Purchase Agreement - Newsfile Corp
- 6 months ago - InMed Announces Publication of Study on Anti-Inflammation by Modulation of Endocannabinoid System - Newsfile Corp